BIOL

Biolase, Inc.
BIOL

Overview Fund Activity
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

47 hedge funds and large institutions have $14.4M invested in Biolase, Inc. in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 6 closing their positions.

Holders
47
Holders Change
+5
Holders Change %
+11.9%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
12
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$1.01M
2
GCP
2
GSA Capital Partners
United Kingdom
$802K
3
EIM
3
Essex Investment Management
Massachusetts
$511K
4
Marshall Wace
4
Marshall Wace
United Kingdom
$481K
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$248K

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$15K
2
State Street
2
State Street
Massachusetts
$267K
3
AG
3
Algert Global
California
$0
4
LFG
4
Larson Financial Group
Missouri
$0
5
Renaissance Technologies
5
Renaissance Technologies
New York
$936K
Name Market Value Shares Shares
Change 		Shares
Change %
HNB
51
Huntington National Bank
Ohio
$0 1 – –
PA
52
Parallel Advisors
California
$0 100 +100 New
Bank of America
53
Bank of America
North Carolina
$0 589 +519 +741%
1 2
3